Dorian Paul LeBlanc - 04 Jun 2026 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Reporting relationship: Chief Financial Officer
Issuer ticker: LMAT
Reported as of: 04 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Jun 2026, 17:33:00 UTC
Prior SEC filing: 30 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Laurie A. Churchill, Attorney-in-fact

Key filing fact

Dorian Paul LeBlanc filed Form 4 for LEMAITRE VASCULAR INC (LMAT) on 05 Jun 2026.

Key facts

This page summarizes Dorian Paul LeBlanc's Form 4 filing for LEMAITRE VASCULAR INC (LMAT).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 05 Jun 2026, 17:33.

Change

Previous filing in this sequence was filed on 30 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002061481 Primary reporting owner

LeBlanc Dorian Paul

Relationship: Chief Financial Officer
Address: C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON
Signature: /s/ Laurie A. Churchill, Attorney-in-fact
Signature date: 05 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LMAT transaction Derivative

Dividend Equivalent Rights

Award

Transaction value
Shares: +2
Change %: +22%
Price: $0.000000^*
Shares after: 14
Date: 04 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2
Exercise price
Footnotes: F1

LMAT transaction Derivative

Dividend Equivalent Rights

Award

Transaction value
Shares: +3
Change %: +118%
Price: $0.000000^*
Shares after: 6
Date: 04 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3
Exercise price
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These dividend equivalent rights accrued on a restricted stock unit award granted on 3/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Footnote F2

These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.